AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference. AtriCure’s management is scheduled to present on Monday, January 10, 2022,...

Click to view original post